Emerging therapy-related kidney disease

Lois J. Arend, Tibor Nadasdy

Research output: Contribution to journalReview articlepeer-review

Abstract

Context.-Many new therapies have emerged within the last 5 to 10 years to treat a variety of conditions. Several of these have direct or indirect renal toxicities that may go undiagnosed without careful attention of the pathologist to a patient's clinical history, particularly the addition of new medications or treatments. Objective.-To discuss patterns of renal injury resulting from medications or therapeutic regimens that have been introduced within the last 10 years. Recognition of these patterns may allow the pathologist to alert the attending clinician to a possible drug-induced renal injury and prevent further deterioration of renal function and possible chronic kidney disease. Data Sources.-A review of recent literature and unpublished observations of case-derived material. Conclusions.-A number of newer therapies have emerged as agents of renal toxicity, producing a variety of pathologic changes in the kidney. The outcome can be acute or chronic glomerular, tubular, interstitial, and/or vascular injury. Some drugs will result in irreversible changes and end-stage renal disease, whereas many of the alterations can be reversed with removal of the offending agent, avoiding potential long-term kidney injury. (Arch Pathol Lab Med. 2009; 133:268-278).

Original languageEnglish (US)
Pages (from-to)268-278
Number of pages11
JournalArchives of Pathology and Laboratory Medicine
Volume133
Issue number2
StatePublished - Feb 1 2009

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Fingerprint Dive into the research topics of 'Emerging therapy-related kidney disease'. Together they form a unique fingerprint.

Cite this